Featured Editor

World-renowned expert in IVF, and on the editorial boards of Human Reproduction Reproductive Biotechnology Online

Dr Cummins在西澳大利亚Murdoc大学从事解剖学、人类生物学和繁殖生物技术的教学工作。在繁殖生物学和辅助生殖技术（如：体外授精）领域拥有丰富的经验。现在多个知名期刊（包括“Human Reproduction and Reproductive Biotechnology Online”）担任编辑，任西澳大利亚繁殖技术理事会科学咨询委员会主席一职（负责监督IVF诊所的政府机构）。10多年来，一直从事专业编辑工作，编辑了2500多篇论文。在亚洲拥有从多同事和朋友，曾在2005年任Osak大学染色体组信息研究中心客座教授。 2009年开始在理文从事编辑工作。

Dr Cummins teaches Anatomy, Human Biology and Reproductive Biotechnology at Murdoch University in Western Australia. He has extensive experience in reproductive biology and assisted conception techniques such as in vitro fertilization (IVF). He sits on the editorial board of several top journals, including Human Reproduction and Reproductive Biotechnology Online, and chairs the Scientific Advisory Committee of the Reproductive Technology Council of Western Australia (the government body overseeing IVF clinics). He has been involved in professional editing for 10 years and has worked on about 2500 papers. He has many colleagues and friends in Asia and was a Visiting Professor at Osaka University's Genome Information Research Center in Japan in 2005. Assoc Prof Cummins began editing for the Edanz Group in 2009.

Featured Editor

Immunology, physiology, anatomy and oncology specialist

Dr Cooke拥有免疫学专业背景，重点研究人体对器官移植的免疫反应。博士学位的主要研究领域是新发现的猪内皮细胞异种抗原的功能意义。曾在关节炎和风湿病理事会（ARC）和英国癌症研究学院（CRUK）任博士后研究员，主攻领域是针对癌细胞将基于抗体融合蛋白工程作为全新治疗手段。专长于酶联免疫吸附试验（ELISA）的设计与使用，PCR和RT – PCR，原代细胞培养，细胞毒性实验，DNA提取、纯化、测序和克隆，高效液相色谱，放射性标记技术、抗原抗体相互作用动力学分析，抗体分离与提纯，以及噬菌体展示技术的使用等。Dr Cooke还是有资质的理疗师，具有人体解剖学和生理学的广博知识。于2009年开始为理文编辑工作。

Dr Cooke’s scientific background is in immunology, with an emphasis on human immune responses to organ transplants. His PhD focused on the functional significance of newly identified xenoantigens expressed by porcine endothelial cells. He has worked as a post-doctoral fellow for both the Arthritis and Rheumatism Council (ARC) and Cancer Research UK (CRUK). The main focus of his post-doctoral work was the engineering of antibody-based fusion proteins specifically targeted to cancer cells, as a novel from of therapy. Dr Cooke has technical expertise in the design and use of enzyme-linked immunosorbent assay (ELISA), PCR and RT-PCR, primary cell culture, cellular cytotoxicity assays, DNA isolation, purification, sequencing and cloning, HPLC, radiolabelling techniques, kinetic analysis of antibody–antigen interactions, antibody isolation and purification and the use of phage display technology. He is also a qualified physiotherapist with extensive knowledge of human anatomy and physiology. Dr Cooke began working with the Edanz Group in 2009.

Featured Editor

Clinical specialist in medical oncology and psychotherapy

Dr Reynolds起初从事肿瘤医学，后转为心理治疗领域。2003年退休，退休前从事临床诊疗，之后开始医学编辑生涯，大部分工作是为日本和中国作者编辑文章。Dr Reynolds是一位成功的作者，已在同行评审期刊上发表了13篇文章，还出版了两本书。2011年加盟理文编辑，担任撰稿人和编辑，除以临床医学为重点外，还编辑其它医疗领域的文稿。

Dr Reynolds initially practiced in Medical Oncology and then Psychotherapy. After retiring from clinical practice in 2003 she began a new career in medical editing. Most of her work has been for Japanese and Chinese authors. A successful author, Dr Reynolds has published 13 articles in peer-reviewed journals, and two books. Dr Reynolds joined the Edanz Group as an editor and writer in 2011 and, though with a clinical focus, works in a broad range of medical fields.

Featured Editor

Formerly a specialist Medical Indexer at Thomson Scientific

Dr Furness在格拉斯哥Beatson癌症研究院从事三年的博士后研究，此期间，利用分子遗传学技术对与癌症（如白血病）发展有关、影响造血干细胞生长的因素进行研究。后任格拉斯哥大学研究员，通过实地观察、放射同位素血液样分析和对海鸟代谢监测，分析海鸟的能量需求。Dr Furness是一位知识渊博的科技编辑，拥有大量的科技论文提炼、索引和编辑经验，涉及的领域包括通用医学、药学和遗传学，在科研实践和发表研究论文方面拥有丰富的个人经历。1993-2007年期间，在Thomson Scientific从事专家医学文摘工作，2007年起为理文编辑工作。

For three years, Dr Furness was a Post-doctoral Research Fellow at the Beatson Institute for Cancer Research, Glasgow, where she used extensive molecular genetic techniques to examine the factors influencing the growth of hematopoietic stem cells, with relevance to the development of cancers such as leukemia. Later Dr Furness was a researcher at Glasgow University where she analyzed the energetic requirements of seabirds, using field observations, analysis of radioisotopes from blood samples and metabolic monitoring of birds in respirometers. Dr Furness is a scientific editor with extensive experience of abstracting, indexing and editing scientific papers on a wide range of topics including general medicine, pharmacology and genetics, with personal experience of active scientific research and the publishing of research papers. From 1993 to 2007, Dr Furness was a Specialist Medical Indexer at Thomson Scientific. She began working with Edanz Editing in 2007.

Dr Huxley持有牛津大学生理科学本科和流行病学研究生双学历。2002年被聘为澳大利亚悉尼大学George学院高级研究员。2007年，曾任悉尼大学医学院的联合副教授和George学院营养与生活方式系主任。过去10年间，发表了90多篇论文，包括Lancet、British Medical Journal、Circulation和JAMA等具有影响力的期刊杂志，是国际会议定期受邀的演讲嘉宾。此外，还曾荣获多项研究殊荣和奖学金。2010年加入理文编辑，担任撰稿人、编辑兼顾问。

Dr Huxley obtained both her undergraduate and graduate qualifications from Oxford University in Physiological Sciences and Epidemiology, respectively. In 2002 she was appointed as a Senior Research Fellow at the George Institute at the University of Sydney, Australia. In 2007, Dr Huxley was appointed Conjoint Associate Professor in the Faculty of Medicine, University of Sydney and Director of the Nutrition and Lifestyle Division within the George Institute. Over the past 10 years, she has published more than 90 research articles, many in high impact journals including The Lancet, British Medical Journal, Circulation and JAMA and is a regular invited speaker at international conferences. Dr Huxley has also been the recipient of several prestigious research awards and fellowships. Dr Huxley began work as a writer, editor and consultant with the Edanz Group in 2010.

Dr Morris拥有肿瘤学（特别是放射生物学、放射线疗法、化学疗法）专业背景。曾在牛津大学作为科研人员和首席研究员，研究癌症新药和新式放疗法的开发。近期作为医学作者和科研员，从事于生物技术的研究和著书。涉及的诊疗领域包括肿瘤、传染病、增龄性黄斑变性和肥胖。曾作为访问学者在美国Brookhaven国家实验室工作。曾在同行审查期刊杂志发表50多篇文章及专书论文。2009年开始为理文编辑工作。

Dr Morris’s scientific background is oncology with an emphasis on radiobiology, radiotherapy and chemotherapy. During the period that he worked as a scientist and principal investigator at the University of Oxford, the focus of Dr Morris’s research was on the development of new drugs and novel forms of radiotherapy for the treatment of cancer. More recently, Dr Morris has worked as a medical writer and scientist in the biotechnology industry. Therapeutic areas that he has been involved with include oncology, infectious diseases, age-related macular degeneration and obesity. Dr Morris has visiting scientist status at the Brookhaven National Laboratory in the US. Dr Morris has written over 50 peer-reviewed journal articles and book chapters. Dr Morris began working with the Edanz Group in 2009.

Featured Editor

Molecular biology expert with 13 peer-reviewed journal articles, as well as invited reviews and two textbook chapters.

13年编辑经验：同行评审期刊杂志、受邀评审、社论和教材上撰稿、编辑、安排版面、发表文章。曾在同行审查期刊发表13篇论文并受邀担任审稿人，编写了教科书中两个章节的内容。自由作家兼编辑。拥有分子生物、细胞生物和生理学背景，写作风格简明扼要。美国医学作家协会和科学编辑理事会会员。2010年开始为理文编辑工作，担任编辑。

Dr Tobin has 13-years' experience in writing, editing, formatting, and submitting peer-reviewed journal articles, invited reviews, editorials, and textbooks. Dr Tobin has authored 13 peer-reviewed journal articles and invited reviews, as well as two textbook chapters. A freelance writer and editor, Dr Tobin combines her background in molecular biology, cell biology, and physiology with a clear, concise writing style. Dr Tobin is a member of the American Medical Writers Association and the Council of Science Editors. She began working as an editor with the Edanz Group in 2010.

Featured Editor

Neurodegenerative disease expert with more than 32 peer reviewed publications

Dr Bijur的研究领域是神经退行性疾病（如老年痴呆症和帕金森氏病）和脑代谢功能。在精神病学和肿瘤形成与癌变领域拥有丰富经验，包括精神分裂症、双相情感障碍、代谢紊乱（如糖尿病）等。对细胞培养技术、分子生物学技术和啮齿类动物模型有透彻的理解。他的个人研究一直由美国国立卫生研究院和精神分裂症与抑郁国家研究联盟提供资助。已撰写32篇同行评审出版物，出席了大量科技学术会议，包括神经科学协会和美国癌症研究协会会议。还担任了多家生物医学期刊杂志和基金发放机构的审稿人。 2010年加盟理文编辑，担任撰搞人和编辑。

Dr Bijur's work is on neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and investigations into brain metabolic functions. Dr Bijur has extensive experience in the areas of psychiatry, including schizophrenia and bipolar disorder, metabolic disorders such as diabetes, and in oncogenesis and carcinogenesis. He has thorough understandings of cell culture techniques, molecular biology techniques, and rodent animal models. His personal research has been funded by the U.S. National Institutes of Health and the National Alliance for Research on Schizophrenia and Depression. Dr Bijur has authored over 32 peer-reviewed publications, and has presented at numerous scientific conferences including the Society for Neuroscience and the American Association for Cancer Research, among others. He also serves as a reviewer for several biomedical journals and granting agencies. Dr Bijur joined the Edanz Group as an editor and medical writer in 2010.

Dr. Davies是一位生物学家，专攻神经系统科学、肿瘤学、染色质结构以及基因表达等领域，在法国波尔多 Université Bordeaux II 大学 François Magendie Institute for Neuroscience、澳大利亚Children’s Cancer Institute等多家研究机构从事过博士后研究工作，期间研究了人β-珠蛋白基因簇染色质结构以及顺铂损伤等课题。Dr. Davies曾担任过几家国际期刊的审稿人，编辑了大量英语母语及非母语作者的稿件。他也以第一作者的身份发表过多篇文章，如“Nucleic Acids Research and The Journal of Pharmacology and Experimental Therapeutics”。他具备丰富的实验室工作经验，包括：急性器官型培养、腺病毒操纵、脑片慢病毒操纵和转导以及神经细胞培养、荧光共焦显微技术、细胞显微注射、活体小鼠模型、蛋白质印迹、电泳凝胶迁移率检测、多种PCR、克隆以及细菌质粒生成等。Dr Davies 从2006年开始为Edanz Editing工作。

Dr Davies is a biologist with particular expertise in the areas of neuroscience, oncology, and chromatin structure and gene expression. Dr Davies has held Postdoctoral Fellow positions at a number of institutes including the François Magendie Institute for Neuroscience, Bordeaux, France, and the Children’s Cancer Institute Australia. During his PhD, he examined chromatin structure and cisplatin damage at the human beta-globin gene cluster. Dr Davies has been a regular reviewer for several international journals and has edited numerous manuscripts written by both native and non-native English speakers. He has a number of first-author publications in journals such as Nucleic Acids Research and The Journal of Pharmacology and Experimental Therapeutics. Dr Davies has experience in a wide variety of laboratory techniques, including acute and organotypic culture, adenovirus manipulation, lentivirus manipulation and transduction of brain slices and cultured neuronal cells, fluorescent and confocal microscopy, cell microinjection, in vivo mouse models, western blot, electrophoretic gel mobility shift assay, PCR (most varieties), cloning and bacterial plasmid production. Dr Davies began working as an editor for Edanz Editing in 2006.

Featured Editor

Previously worked in a biotechnology company that focused on a radioactive peptide as targeted therapy for neuro-oncology

Dr Schade-Bijur的博士学位研究重点是确定人类大脑神经细胞钠离子通道的启动区，研究成果已在神经科学学会的一次国际会议上宣讲，并在同行评审期刊上发表。拥有精湛的高度分子生物学领域技术，包括：克隆、基因、DNA和蛋白质提取、RT - PCR检测、杂交、测序和凝胶电泳。曾在一家生物技术公司工作7年，重点研究神经肿瘤靶向治疗放射肽。作为科学家和高级制造经理，针对各种组织进行了生理组织学实验（包括使用组织切片机备制切片），研究卵母细胞的提取和神经胶质瘤氯离子通道。另外还负责临床药学，是编写基金申请和规范性文件的临床小组成员。发表了基于实践经验的两篇同行评审论文（包括临床试验论文）。作为一名自由撰稿人，其写作领域涉及卫生经济学和医学教育（关于癌细胞血管生成），撰写了50多份脂质产品技术公告。科技写作背景丰富，2010年加盟理文编辑，主要从事神经学和肿瘤领域的撰稿和编辑。

Dr Schade-Bijur’s PhD focused on identifying the promoter region of a neuronal sodium channel in the human brain. Dr Schade-Bijur’s work from these studies has been presented at an international Society of Neuroscience meeting and published in peer-reviewed journals. She is highly skilled in molecular biology techniques, such as cloning, mRNA, DNA and protein extraction, RT-PCR, blotting, sequencing and gel electrophoresis. For seven years Dr Schade-Bijur worked in a biotechnology company that focused on a radioactive peptide as targeted therapy for neuro-oncology. As a scientist and the Senior Manager for Manufacturing, Dr Schade-Bijur performed histology experiments for various tissues, including using a microtome for tissue slice preparation, and oocyte extraction and electrophysiology on a glioma chloride channel. Dr Schade-Bijur was also in charge of the clinical pharmacy and was part of the clinical team writing grants and regulatory documents. From this research she published two more peer-reviewed papers, including a clinical trial paper. As a freelance writer, Dr Schade-Bijur has written in the areas of health economics, medical education regarding cancer angiogenesis and over 50 technical bulletins about lipid products. Dr Schade-Bijur has a particularly broad science and writing background. She joined the Edanz Group as a writer and editor in 2010, specializing in the fields of neuroscience and oncology.

Dr Colebrooke的博士研究课题是“帕金森多巴胺大鼠模型的分子、神经生化和行为分析”。之后成为英国Babraham Institute分子神经科学实验室博士后研究员。熟悉各种常用实验室技术、试验和小动物模型。曾多次以第一作者身份在国际期刊杂志上发表文章。2006年开始为理文编辑工作，任编辑一职。

Dr Colebrooke’s PhD title was “Molecular, neurochemical and behavioural analyses of a novel dopamine-depleted mouse model of Parkinson’s disease.” She then was a post-doc research scientist in the Laboratory of Molecular Neuroscience, The Babraham Institute, UK. Dr Colebrooke is familiar with all the usual laboratory techniques and tests, along with small animal models. Dr Colebrooke has several first-authored publications in international journals. She began as an editor with Edanz Editing in 2006.

Dr Roth发表的文章涉及以下领域：T细胞生物学、基因重排的分子机制、发育生物学、神经生物学、核受体生物学。在转基因动物模型、开发基因组和蛋白质组技术、运用基因和蛋白质表达谱方法进行疾病诊断和治疗（包括糖尿病、肥胖、血液疾病和肿瘤）等方面拥有丰富经验。联合撰写并在影响力极高的杂志上发表了13篇文章，同时还和专利发明人联合撰写了5篇专利书。曾为知名生物制药、医疗设备和生物科技等公司提供有关平台技术和产品开发方面的顾问建议。多年担任昆尼皮亚克大学客座教授，在线授课生物学本科课程。在美国西北大学期间，获美国癌症学会博士后奖学金；在纽约冷泉港期间，研究发育神经生物学。于2010年开始为理文编辑工作，担任编辑。

Dr Roth has published articles on T cell biology, the molecular mechanisms of gene rearrangement, hematopoeisis, developmental biology, neurobiology, and nuclear receptor biology. He has extensive experience with transgeneic animal models, developing genomic and proteomic based technologies, and applying gene and protein expression profiling methods to diseases and therapeutic areas, including diabetes, obesity, blood disorders, and oncology. He is a co-author on 13 publications in high impact journals, and the co-inventor on five issued patents. He has consulted with leading biopharmaceutical, medical device, and life science companies on new platform technologies and product development. As an adjunct professor at Quinnipiac University, he taught an undergraduate online biology course for several years. He received an American Cancer Society Postdoctoral Fellowship while at Northwestern University, and studied developmental neurobiology at Cold Spring Harbor, New York. Dr Roth began working with Edanz Editing as an editor in 2010.

Dr Parker的博士研究领域是癌生物学和信号传导，后在佛罗里达大学射线肿瘤科从事博士后研究。现为New York Journal of Books科技文章审稿人。2010年开始为理文编辑工作，担任医学作者和编辑。

Dr Parker’s PhD studies were in the field of cancer biology and signal transduction. Her post-doctoral research was in the Department of Radiation Oncology at the University of Florida. Dr Parker is presently a science reviewer with the New York Journal of Books. She began working with the Edanz Group as a medical writer and editor in 2010.

Dr March是癌症生物学家，主要研究领域是细胞信号传导和肠道肿瘤学。博士课题内容是研究MAP激酶通路对AP- 1蛋白的调节。目前任英国剑桥大学肿瘤研究所高级博士后研究员，工作重点是应用新模型来判定和表征大肠癌的新驱动基因。此前在英国Babraham研究所做博士后研究，工作内容是与UCB制药公司合作，研究癫痫药物的作用模式。另外还曾在生物技术行业工作。多次受邀在国内和国际上讲学，并在一些国际同行评审期刊发表过文章2011年初加入理文，担任编辑。

Dr March is a cancer biologist with special interests in cell signaling and intestinal oncology. Her PhD research examined the regulation of AP-1 proteins by MAP kinase pathways. Dr March is currently a Senior Postdoctoral Research Fellow at the Cancer Research UK Cambridge Research Institute, where her work focuses on the application of innovative models to identify and characterize novel driver genes in colorectal cancer. Previously, Dr March was a Postdoctoral Research Scientist at the Babraham Institute, UK, where, in collaboration with UCB Pharma, she studied the mode of action of an anti-epilepsy drug. She also has experience working in the biotechnology industry. Dr March has given invited lectures both nationally and internationally, and has published in several international peer-reviewed journals. Dr March joined Edanz as an editor in early 2011.

Dr Steen从事于与人脑有关的研究工作；包括从人类行为到分子生物学，以及介于两者之间的所有主题。一直从事脑成像方面的研究工作，利用磁共振成像技术研究儿童脑卒中（特别是脑卒中的血液和基因风险）。曾是精神病学以及放射学、儿科和生物医学工程副教授。在学术性科学文献上发表有80篇论文，著有6本著作以及多篇专书论文。在脑成像和临床神经学领域颇有建树，另外还撰写了流行病学、遗传、运动生理学、心理学、过敏反应、心脏病学、睡眠医学、肺病学、整形外科、研究伦理、甚至无脊椎动物学等领域的文章。2010年加入理文编辑，从事写作和编辑工作。

Dr Steen’s experience is related to anything to do with the brain, from human behavior to molecular biology and everything in between. He has done brain imaging research, using MRI to study pediatric stroke (particularly hematologic and genetic risk factors for stroke). Dr Steen has held Associate Professor positions in Psychiatry, as well as in Radiology, Pediatrics, and Biomedical Engineering. He has published 80 papers in refereed scientific literature, as well as 6 books and many book chapters. His specialties are brain imaging and clinical neurology, but Dr Steen has also written in the fields of epidemiology, genetics, exercise physiology, psychology, allergy, cardiology, sleep medicine, pulmonology, orthopedics, research ethics, and even invertebrate zoology. Dr Steen joined the Edanz Group as a writer and editor in 2010.

Dr Bradshaw是一位在生物医学科学和医疗保健领域有深厚研究功底的临床专家，欧洲医学作家协会成员，发表了17篇科技文章。2007-2008年间，当选为英国皇家内科医院指南开发小组和指导小组成员，负责指导《国家健康服务》指南的发表。还作为第一作者为英国皇家内科医学院撰写了关于“职业视力标准”，作为眼科的全国准则。在数家顶尖期刊从事同行评审工作，其中包括：《美国眼科学杂志》、《航空航天与环境医学》和《英国全科医疗学刊》。Dr Bradshaw 是医疗与生物科学的全面手专家编辑。于2010年加盟理文编辑，担任撰搞人和编辑。

Dr Bradshaw is a clinical specialist with a strong background in biomedical science and healthcare related research. He is a member of the European Medical Writers Association (EMWA), and has published over 17 scientific papers. In 2007/8, Dr Bradshaw sat on the board as an elected member of both the Royal College of Physicians guideline development and steering groups, leading to the publication of National Health Service guidelines. He also first-authored the UK national guidelines on “Occupational Visual Standards” for the Royal College of Ophthalmologists. He is a peer reviewer for several top journals including: the American Journal of Ophthalmology, Aviation Space and Environmental Medicine and the British Journal of General Practice. Dr Bradshaw is a specialist editor across a wide variety of medical and bioscience topics. He joined the Edanz Groups as an editor and writer in 2010.

Dr. Dean的博士论文题目是“Endogenous Neural Excitation and Inhibition and the Evolution of Preterm Brain Injury”。目前正在从事神经系统科学领域的博士后研究工作。具有大型动物和胎儿外科手术经验，包括导管和电极置放、动物解剖、微透析和激光多普勒超 声探头立体定位。在电生理学领域里，DR. Dean具有丰富的活体电生理数据的仪器测量、记录和分析经验，包括大脑皮层脑电图棘波和癫痫发作活性、脑阻抗、脑近红外光谱(NIRS)、脑部激光多普 勒、温度、ECG、EMG、血压、超声血流量测量以及胎儿呼吸运动。此外，他还掌握系统生理学方面的知识，了解复杂和罕见的心血管和中枢神经系统反应。在 分子学领域中，Dr. Dean掌握多种印迹分析方法、引物设计和序列分析、mRNA和蛋白质提取、RT-PCR及凝胶电泳等技术。他在组织学方面的技能包括脑组织染色和分析以 及成像，对于相关的实验室技巧也具有丰富的经验。Dr. Dean从2007年期开始为Edanz Editing工作，主要编辑化学和神经系统科学领域的文章。

Dr Dean’s PhD thesis was titled “Endogenous Neural Excitation and Inhibition and the Evolution of Preterm Brain Injury.” Dr Dean is presently a post-doctoral research fellow in fields related to neuroscience. He has experience in large animal and fetal surgery techniques, including catheter and electrode placement and animal post-mortem and dissections, as well as in stereotaxic placement of microdialysis and laser Doppler probes. In electrophysiology, Dr Dean is skilled in the instrumentation, recording, and analysis of electrophysiological data in vivo, including cortical EEG spike wave and seizure activity, cerebral impedance, cerebral near-infrared spectroscopy (NIRS), cerebral laser Doppler, temperature, ECG, EMG, blood pressure, ultrasonic blood flow measurement, and fetal breathing movements. He possesses training in systems physiology, as well as an understanding of the complex and unique cardiovascular and central nervous system responses. In molecular fields, Dr Dean covers the various blot analysis techniques, primer design and sequence analysis, mRNA and protein extractions, RT-PCR and gel electrophoresis. Histology including staining and analysis of brain tissue and imaging and the associated laboratory skills are all areas in which Dr Dean has experience. Dr Dean began as an editor for Edanz Editing in 2007, and works in fields related to chemistry and neuroscience.

Dr Leslie曾从事过生物化学和分子生物学研究，主要从事癌症、老化和病毒性疾病的分子生物学研究。2000年，在“日本科学与技术”基金的资助下，于神奈川县癌症研究中心研究所进行干细胞研究。次年，在东京大学进行抗癌化合物研究。随后3年内，在日本理化学研究所从事蛋白质产生与分析。2006年进入制药公司担任协调人和医学撰稿人；2010年加盟理文编辑，任撰稿人和编辑。

Dr Leslie Bestilny’s PhD was in biochemistry and molecular biology. His research focused on the molecular biology of cancer, aging and viral diseases. In 2000 he received a Japan Science and Technology (STA) scholarship to research stem cells at the Kanagawa Cancer Research Center Institute. The following year he performed research of anti-cancer compounds at The University of Tokyo. This was followed by 3 years of protein production and analysis at RIKEN Institute. He joined Pharma Inc. in 2006 as a coordinator and medical writer, and in 2010 began working with the Edanz Group as a writer and editor.

Featured Editor

Neuroendocrinology and tumor biology expert

Dr Cleary是生物医学科学家，专注癌症研究和慢性疾病研究。博士论文题目是“从嗜铬细胞到嗜铬细胞瘤：对交感神经链的探讨”。曾在国家神经疾病和中风研究院（NIH）任博士后研究员，作为首席研究员负责一项转移性肾脏疾病治疗新战略研究的项目。在癌肿瘤生物学和癌症发展起源研究方面积累丰富经验，特别是与von Hippel-Lindau gene抑癌基因突变相关的课题。对卫生政策有浓厚的兴趣，曾在美国国立卫生研究院福格蒂国际中心任研究员。在此期间，参与了多项全球卫生政策项目。在同行评审期刊上发表了大量文章，另外还出版了面向非技术性读者的科技文章。2010年加盟理文，从事编辑工作。

Dr Cleary is a biomedical scientist with a special interest in cancer research and chronic disease. Her doctoral thesis was entitled “From chromaffin cells to phaeochromocytoma: insight into the sympathoadrenal lineage”. Dr Cleary was a Post Doctoral Fellow with the National Institutes of Neurological Disorders and Stroke (NIH), where she was the lead researcher on a project investigating novel strategies for the treatment of metastatic kidney disease. Dr Cleary has an extensive history of research in cancer tumor biology and an interest in the developmental origins of cancer, especially those related to mutations of the von Hippel-Lindau gene. Dr Cleary has an interest in health policy and was a Fellow with the Fogarty International Center at the NIH. During this time she was involved in a number of global health policy projects. Dr Cleary has published a number of articles in peer-reviewed journals in addition to other science writing for a non-technical audience. Dr Cleary began working as an editor for the Edanz Group in 2010.

英国爱丁堡大学药理学研究员、伦敦大学和牛津大学研究助理、阿伯丁大学生理学讲师。在阿伯丁大学，她还建立了电生理实验室，用以研究药物作用与哺乳动物心室肌细胞电活动的关系。Dr Cant拥有丰富的写作和编辑经验，曾为欧共体Cordis Results and Publications数据库和BEST（英国科技专家）数据库及其在美国的姐妹数据库编辑生物和物理科学类文章。多年任Thomson Scientific医学编辑、数据库编索人，拥有心血管病学、肠胃病学、神经科学、流行病学、药理学和生理学领域的知识背景。

Dr Cant has been a Research Fellow (Pharmacology) at the University of Edinburgh and a Research Assistant at the University of London and the University of Oxford, as well as a Lecturer in Physiology at the University of Aberdeen where she also established an electrophysiology laboratory for investigation of drug effects on electrical activity in isolated mammalian cardiac ventricular cells. Dr Cant also has extensive writing and editing experience, having edited papers in biological and physical sciences for the European Community CORDIS Results and Publications databases, as well as for the BEST (British Expertise in Science and Technology) database and its sister database in the US. Dr Cant was a medical editor/database indexer for Thomson Scientific for a number of years and has a wide knowledge of various areas including cardiovascular disease, gastroenterology, neuroscience, epidemiology, pharmacology and physiology.

原就读格拉斯哥大学微生物学，后去阿伯丁大学疱疹病毒学攻读博士学位。之尔后主攻电子显微镜，又继续了几年超声波治疗癌症的博士后研究，后来又取得信息学文凭，自1991年起从事医疗与药品信息工作。曾为EMBase和几家医药数据库担任文摘；多家期刊杂志（其中包括Lancet Infections Diseases and Lancet Oncology）新闻撰稿人；任Springer和Society for General Microbiology编辑。除编辑工作外，还帮助数家知名药业公司建立产品文献数据库。2005年加盟理文编辑，主要编辑医学和生命科学方面文章，尤其是微生物学和传染病学。是普通微生物学会会员。

Dr Kerr originally studied microbiology at Glasgow University and went on to complete a PhD on herpes viruses at Aberdeen University. He then specialized in electron microscopy and continued for a few years in post-doctoral research on ultrasound treatment of cancer. This was followed by a diploma in information studies, and he has worked in medical and drug information since 1991. Dr Kerr has worked previously as an indexer for EMBase and other pharmaceutical databases, a news writer for several journals including Lancet Infections Diseases and Lancet Oncology, and as a copyeditor for Springer and the Society for General Microbiology. In addition to editing, he works on product literature databases for a number of leading pharmaceutical companies. Dr Kerr joined the Edanz Group in 2005 and edits in the medical and life sciences, with a particular interest in microbiology and infectious diseases. He is a member of the Society for General Microbiology.

职业经历

Dr. Thompson 主要致力于肾生理学/内分泌学、糖尿病和生殖学领域的科学研究。在博士研究阶段，她深入探究了类固醇代谢对肾功能的影响，并通过博士后阶段进一步研究了各种系统(包括人类胎盘和糖尿病模型鼠)中的类固醇代谢。她还研究了葡萄糖毒性对糖尿病动物模型细胞内信号传导的影响。研究技能包括：类固醇放射免疫试验，组织学，mRNA/DNA 提取和纯化，RT-PCR， 原位 RT-PCR，原代细胞培养，DNA 纯化、复制及足迹法，Northern、Southern 和 Western 免疫印迹，光学/荧光/共焦显微法等。Dr. Thompson 具有出色的写作技巧，著有大量的同行评审期刊文章，从事了五年的全职医学作者工作，写作范围涉及糖尿病学、胃肠病学、免疫学、肿瘤学和哮喘等众多领域。Dr. Thompson 从 2008 年起开始为 Edanz Editing 工作。

Dr. Thompson's scientific background is in physiology with an emphasis on renal physiology/endocrinology, diabetes and reproduction. For her PhD she investigated the effects of steroid metabolism on renal function and as a Postdoctoral Fellow she focused on steroid metabolism in various systems including human placenta and diabetic mice models. She also investigated the impact of glucose toxicity on intracellular signaling in diabetic animal models. Technical skills include steroid radio-immunoassay, histology, mRNA/DNA extraction and purification, RT-PCR, in situ RT-PCR, primary cell culture, DNA purification, cloning and footprinting, Northern, Southern and Western blots and light/fluorescence/confocal microscopy. Dr. Thompson has excellent writing skills and has written numerous peer-reviewed journal articles. She has over 5 years’ experience as a full-time Medical Writer in a wide range of topics including diabetes, gastroenterology, immunology, oncology and asthma. Dr Thompson began working with Edanz Editing in 2008.

Brunker 女士具有二十余年生物医学领域稿件的编辑经验，包括向同行评审期刊投稿的文章、学位论文和学术文章、向美国监管机构（食品和药品管理局以及美国专利商标局）递交的申请材料；各种药物广告、网站内容、演讲稿、论文以及会议等场合所需的材料；同时还包括广泛的医学教学资料。她的硕士学位论文探讨了HIV+ CD4+ 细胞的凋亡。还曾参与过乳癌和环境医学的实验室工作。

Ms Brunker has been editing biomedical documents for over two decades, including submissions to peer-reviewed journals, dissertations and other academic papers, applications to US regulatory agencies (the Food and Drug Administration and the Patent and Trademark Office), pharmaceutical advertisements of all types, Web site content, slide presentations, scripts and other support pieces for conferences and similar events, and a wide variety of medical education materials. Her master’s thesis was on apoptosis in HIV+ CD4+ cells. She has also done laboratory work in breast cancer and environmental medicine.

医学和科学编辑/撰稿人，拥有为医疗机构和药品广告研究机构进行生命科学内容开发的经验。最初任加拿大蒙特利尔戴维斯夫人医学研究院癌症研究实验室研究助理，进行分子和细胞生物学实验，内容包括：mRNA、DNA和蛋白质提纯、Northern 和Western杂交、RT - PCR、细胞运输、原代组织培养、各种药物疗效研究。还撰写了期刊杂志的投稿和向资助机构提供的实验室文件。后又从事医药广告工作8年，负责校对、审稿和事实审查；撰写了医学教育计划（向医师和护理人员传授药品标签方面的知识）。同时还是经验丰富的医学与科学自由撰稿人和编辑，为各种研究实验室和企业实体供稿。于2009年开始为理文编辑工作，担任编辑。

Ms Malapetsas is a medical and scientific editor/writer with experience in the development of content in the various areas in the life sciences for both medical research institutes and pharmaceutical advertising agencies. Initially a research assistant in a cancer research laboratory at the Lady Davis Institute for Medical Research in Montreal, Canada, she performed molecular and cellular biology experiments—including mRNA, DNA, and protein extraction and purification, Northern and Western blots, RT-PCR, cellular transport, primary tissue culture, and various drug efficacy studies. She also developed laboratory documents for submission to journals and funding agencies. Ms Malapetsas then worked in pharmaceutical advertising, where for eight years she undertook proofreading, copyediting, and fact-checking, and wrote medical education programs delivering on-label drug information to physicians and healthcare professionals. Ms Malapetsas also has extensive experience as a freelance medical and scientific editor/writer for research laboratories and corporate entities. Ms Malapetsas began working as an editor with the Edanz Group in 2009.

科技与医学作家，编辑经验涉及广泛的医学和生命科学领域。硕士论文涉及抗微生物制剂的开发，用以防治抗药性细菌。曾执教于North Carolina-Greensboro大学，讲授生物学和微生物学，同时还研究肥胖、炎症、胰岛素抵抗之间的联系。曾与他人合作撰写了7份在同行评审期刊上发表的科技文章以及一篇专书论文。持有生物医学研究生写作证书，是生命科学认证编辑（ELS）。作为编辑，编辑了数以百计的研究文章；作为作家，为药业和生物技术业编写了有关健康与医疗的文章。自2010年起为理文编辑工作，担任编辑。

Ms LaPoint is a science and medical writer-editor with experience in a wide range of medical and life science topics. Her master’s thesis involved the development of antimicrobial agents to prevent and treat antibiotic-resistant bacteria. Ms LaPoint has taught biology and microbiology at the University of North Carolina-Greensboro, where she also conducted research investigating links between obesity, inflammation, and insulin resistance. She has co-authored seven scientific manuscripts published in peer-reviewed journals and one scientific book chapter. Ms LaPoint also has a post-graduate biomedical writing certificate and is a board-certified editor in the life sciences (ELS). As an editor she has edited hundreds of research manuscripts, as a writer she has written about health and medical topics for the pharmaceutical and biotechnology industries. She began working as an editor and writer with the Edanz Group in 2010.

Featured Editor

Specialist in Veterinary medicine

6年外科医学和动物医学经验，目前的工作身份是美国全科医师。Dr Morben在编辑和校对各种科研文章上丰富经验。美国医学作家协会成员。2010年起为理文编辑工作，担任编辑。

Dr Morben has six years of experience in veterinary medicine. She currently works as a general practitioner in the United States. In addition, Dr Morben has extensive experience editing and proofreading a wide variety of research manuscripts and is a member of the American Medical Writers Association. Dr Morben began working as an editor with the Edanz Group in 2010.

2002至2009年在中国浙江大学生命科学学院担任研究员和讲师，讲授撰写和发表科技论文原则的研究生课程。2009年起，为日本一所大学的Global Center of Excellence for Asian Conservation Ecology项目提供编辑支持。研究并发表报告的领域包括与含铁血黄素沉着症（铁贮积症）有关的人类和动物医学，主要集中在生态学、农业和保护生物学领域。Wood先生还在中国第一家国家湿地公园 — 西溪国家湿地公园生态顾问小组担任组长。赴中国工作前，曾是一位灵长类动物学家，最初研究马达加斯加狐猴，后来研究旧大陆猴。一直在英国牛津布鲁克斯大学担任定期客座讲师。自2010年起在理文编辑从事编辑工作。

From 2002 to 2009, Mr Wood was a researcher and lecturer for the College of Life Sciences of Zhejiang University in China. He taught post-graduate level principles of how to write and publish scientific papers. In 2009, he began providing editorial support at a Japanese university for the Global Center of Excellence for Asian Conservation Ecology program. Mr Wood has researched and published in various fields including Hemosiderosis (Iron Storage Disease) linking human and animal medicine, his published reports have focused on ecology, agriculture and conservation biology. Mr Wood has also worked as a team leader for the ecological consultancy of China’s First National Wetland Park, Xixi Wetlands. Prior to moving to China, Mr Wood was a primatologist focusing initially on the lemurs of Madagascar but later on old world monkeys. He has been a regular visiting lecturer for Oxford Brookes University in the UK. Mr Wood began editing for the Edanz Group in 2010.

Wallace先生的专业背景是生物化学和遗传学。后曾从事生物医学和生物工程研究，特别是周围神经系统和中枢神经系统的神经再生。博士期间的研究主要涉及脊髓损伤的组织工程学，结合采用新型神经导管作为细胞载体，促使神经系统轴突再生。该项目还研究了对神经干细胞采取最佳的细胞分离方法，利用水凝胶优化神经导管。在以下领域经验丰富：组织提取和细胞培养、病毒转导、电纺丝、扫描电子显微镜、荧光显微镜、骨架冻干处理、骨胶原分离、RT-PCR、SDS-PAGE、核酸杂交技术和组织学。2004–2006年期间，曾作为科学信息专家，服务于Thomson Scientific & Healthcare。期间，负责分析已发表的生命科学和生物医学文章并从中筛选所需信息，从而实现与Web of Science数据库约8,700种知名研究杂志中的多学科信息的无缝对接。曾作为BIOSIS Previews质量控制小组成员，负责撰写科学文章摘要。2009年加入理文编辑，从事编辑工作。

Mr Wallace’s background is in biochemistry and genetics. Later he focused on biomedical science/bioengineering, in particular nerve regeneration in both the peripheral and central nervous systems. His PhD focuses on tissue engineering for spinal cord injury and combines the use of novel nerve guides as cell carriers for the promotion of axonal regeneration. This project also looks at optimal cell isolation protocols for neural stem cells and optimization of nerve conduits using hydrogels. He is experienced in tissue extraction and cell culture, viral transduction, electrospinning, scanning electron microscopy, fluorescence microscopy, freeze-dry processing of scaffolds, collagen isolation, RT-PCR, SDS-PAGE, Southern blotting and histology. He has also worked as a Scientific Information Specialist for Thomson Scientific & Healthcare during 2004–2006. In this position he was responsible for analyzing and extracting information from life science and biomedical articles to allow for seamless access to current and retrospective multidisciplinary information from approximately 8,700 high-impact research journals from the Web of Science. He also worked as part of the quality control team for BIOSIS Previews, where he was required to write abstracts for scientific articles. Mr Wallace began working as an editor for the Edanz Group in 2009.

Dr Donkin的博士论文题目是“神经肽P物质对大鼠创伤性脑损伤后果的作用”。研究兴趣还包括利用啮齿动物模型开发用于治疗脑外伤和神经退行性疾病的新药物治疗剂。已完成在加拿大不列颠哥伦比亚大学的博士后研究，研究在预防和治疗阿尔茨海默氏病中采用防治化合物的可能性。Dr Donkin已发表多篇同行评审期刊文章，目前的职业是科研作家。2011年加入理文，担任科技编辑、撰稿人和审稿人。

Dr Donkin's PhD thesis was entitled "The Effects of the Neuropeptide Substance P on Outcome Following Traumatic Brain Injury in Rats". His research interests include developing novel pharmacotherapeutic agents for the treatment of neurotrauma and neurodegeneration using rodent animal models. He has completed a post-doctoral fellowship at the University of British Columbia, Canada, investigating potential prophylactic and therapeutic compounds in the prevention and treatment of Alzheimer's disease. Dr Donkin has published several peer-reviewed journal articles and currently works as a scientific writer. Dr Donkin joined the Edanz Group as a science editor, writer and reviewer in 2011.

Dr Eager目前是美国德克萨斯州达拉斯的一名住院部医师。在过去10年里，已积累了丰富的临床研究和临床前研究经验，重点是肿瘤学领域。曾任玛丽克劳利癌症研究中心机构审查委员会成员6年，在此期间，审阅了大批I阶段到III阶段临床试验协议。除临床经验外，Dr Eager 还在体外临床前协议与技术、细胞培养和组织学方法等领域拥有丰富经验，拥有广博的微生物技术知识。Dr Eager撰写并合作撰写了8份出版物，起草了4份临床/临床前研究协议。Dr Eager去年一直兼职科技稿件专业编辑，2011年起加盟理文编辑，担任编辑。

Dr Eager currently practices internal medicine as a hospitalist in Dallas, Texas, USA. Over the past decade he has amassed considerable experience in clinical and pre-clinical research, principally in the field of oncology. He was a member of the Mary Crowley Cancer Research Center Institutional Review Board for six years, during which time he reviewed numerous Phase I through Phase III clinical protocols. In addition to his clinical expertise, Dr Eager has experience with in-vitro pre-clinical protocols and techniques as well as cell culture, histological methods, and animal model studies, and is skilled in a wide range of microbiology techniques. Dr Eager has authored and co-authored eight publications, and has authored four clinical or pre-clinical protocols. On a part-time basis, Dr Eager has edited scientific manuscripts professionally for the past year and began editing for the Edanz Group in 2011.

Dr Zagami的主要研究领域是神经系统的正常发育和功能、以及神经系统疾病的异变过程。早期研究涉足运动神经元病肌萎缩性侧索硬化症（ALS）脊髓薄片器官型培养模式的开发。曾对肌萎缩性侧索硬化症中的两个过程 — 谷氨酸转运体功能和细胞死亡中神经兴奋性毒性和氧化应激的作用进行分析。主要专注于星形胶质细胞的研究及其在调节谷氨酸转运体中的作用、以及这些机制对运动神经的影响。Dr Zagami的博士后研究在加拿大麦吉尔大学蒙特利尔神经科学研究所完成，通过研究在神经元系亚类分化中以及其它神经领域的轴突靶向中发挥重要作用的蛋白质，从而深入了解某些脑干神经元群的发育。2011年加盟理文，担任编辑。

Dr Zagami's scientific research has focused on the study of the normal development and function of the nervous system and the aberrant processes underlying neurological diseases. Her early studies involved the development of an organotypic spinal cord slice culture model of the motor neuron disease amyotrophic lateral sclerosis (ALS). Dr Zagami's PhD studies examined the roles of excitotoxicity and oxidative stress, two processes implicated in ALS, on glutamate transporter function and cell death. Particular attention was focused on astrocytes and their role in regulating glutamate transporters, as well the effect of these mechanisms on motor neurons. Dr Zagami’s postdoctoral work at the Montreal Neurological Institute, McGill University, Canada, aimed to gain a better understanding of the development of certain brainstem neuronal populations by focusing on a protein with an important role in neuronal subtype specification and axon targeting in other areas of the nervous system. Dr Zagami joined the Edanz Group as an editor in 2011.

Dr Hitchin，有机合成化学家，拥有8年多制药和精细化工行业经验，精于合成化学、药物化学和工艺研究与开发。博士学位的研究课题是多官能基化奎宁环的合成与应用。目前任职于英国癌症研究中心高级科学主任，该中心设于英国百德新癌症研究所，在那里他带领一组药物化学专家研究肿瘤药物的新靶点。Dr Hitchin还曾任肯特郡 Sandwich实验室辉瑞全球研究与开发项目的化学组组长，负责设计和实施所有治疗方面的综合战略（包括疼痛、肥胖和病毒学），取得了很大成功。此外，还曾在一家由美国FDA批准工厂从事C – GMP生产。已在同行评审期刊上发表过多篇文章。2011年加盟理文编辑，担任编辑。

Dr Hitchin is a synthetic organic chemist with over eight years of experience in the pharmaceutical and fine chemical industries. He is skilled in the areas of synthetic chemistry, medicinal chemistry and process research and development. Dr Hitchin’s PhD investigated the synthesis and application of poly-functionalized quinuclidine systems. He is currently a Senior Scientific Officer for Cancer Research UK at the Paterson Institute of Cancer Research in the UK, where he leads a team of medicinal chemists investigating novel drug discovery targets in oncology. Dr Hitchin has also worked as a Chemistry Group Leader for Pfizer Global Research and Development at the Sandwich laboratories in Kent, UK, where he was responsible for the successful design and implementation of synthetic strategies across therapeutic areas including pain, obesity and virology. Further to this, Dr Hitchin has worked providing c-GMP manufacture in an FDA approved facility. Dr Hitchin has published in several peer-reviewed journals. He joined the Edanz Group as an editor in 2011.

Featured Editor

Has edited and/or authored over 200 publications in textbooks and top-tier peer-reviewed journals, including the American Journal of Clinical Nutrition, Nature, Journal of the American Dietetic Association, Journal of Nutrition, and Nature Cardiovascular

作为获奖医学作家，拥有13年为全球主要权威机构撰写、编辑文章的丰富经验，涉及领域包括糖尿病、肥胖症、心血管病、高血压、癌症、营养学、减肥手术、产科、流行病学、公共卫生和微创手术。擅长对即将出版的原稿进行综合处理，包括撰写、编辑和校对，已编辑和撰写了200多件出版物。作品已选入教科书并刊登在一流同行评审期刊上，如“American Journal of Clinical Nutrition”、自然、Journal of the American Dietetic Association、Journal of Nutrition和Nature Cardiovascular。仅用3年时间便以最优异的成绩从美国马萨诸塞州波士顿大学毕业，获传播学学位。近期编辑了由Frank B. Hu（医学博士、哲学博士，哈佛大学公共卫生学院营养学与流行病学教授、哈佛波士顿医学院医学教授）所著《肥胖流行病学》（Obesity Epidemiology），由牛津大学出版社出版。2010年加盟理文编辑，担任编辑和撰稿人。

Ms Buckley is an award-winning medical writer with 13 years of experience writing and editing for some of the world’s leading authorities in the fields of diabetes, obesity, cardiovascular disease, hypertension, cancer, nutrition, weight loss surgery, obstetrics, epidemiology, public health, and minimally invasive surgery. She specializes in the delivery of publication-ready manuscripts being involved in a combination of writing, editing, and proofreading services. Ms Buckley has edited and/or authored over 200 publications. Her work has been published in textbooks and top-tier peer-reviewed journals, including the American Journal of Clinical Nutrition, Nature, Journal of the American Dietetic Association, Journal of Nutrition, and Nature Cardiovascular. Ms Buckley graduated summa cum laude in three years from Boston University (Boston, MA, USA) with a degree in Communications. She recently edited Obesity Epidemiology (Oxford University Press) by Frank B, Hu, M.D., Ph.D., Professor of Nutrition and Epidemiology, Harvard School of Public Health, Professor of Medicine, Harvard Medical School (Boston, USA). Ms Buckley joined the Edanz Group as an editor and writer in 2010.

Dr J. Ludovic Croxford是一位多学科免疫学家，拥有多个领域的研究经验，尤其在神经免疫学、自体免疫和肿瘤学领域。博士期间的研究课题是证明细胞因子基因治疗在治疗动物模型自体免疫疾病中的应用可能性，博士后阶段主要针对诱发自体免疫疾病的病毒性分子模拟的机制进行研究。随后于日本东京国立神经和神经医疗研究中心下属国立神经学研究所对新型NKT细胞在多发性硬化模型中的作用进行研究。之后，从事白血病免疫性疾病肿瘤的抑制机制的研究。Dr Croxford曾在Nature、Nature Immunology和Nature Medicine等多种期刊杂志上发表40余篇同行评审论文、评论和专书论文。2011年12月加入理文编辑。

Dr J. Ludovic Croxford is a multi-disciplinary immunologist with research experience in a wide range of fields, especially neuroimmunology, autoimmunity and oncology. His PhD research demonstrated the potential use of cytokine gene therapy for the treatment of animal models of autoimmune disease, and his post-doctoral research focused on the mechanisms of viral molecular mimicry to induce autoimmunity. Dr Croxford next studied the role of a novel NKT cell in a multiple sclerosis model at the National Institute of Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan. Following this he studied the mechanisms of immune-mediated tumor suppression for leukemia. Dr Croxford has published over 40 peer-reviewed papers, reviews and book chapters in journals including Nature, Nature Immunology and Nature Medicine. Dr Croxford joined the Edanz Group as an editor in December 2011.

Dr Anderson的博士研究主要集中在锰毒性和缺铁对神经递质GABA和去甲肾上腺素的生物学影响。Dr Anderson现于美国弗吉尼亚大学补充与替代疗法研究中心从事博士后研究。研究领域包括：预防和控制神经退行性疾病（如阿尔茨海默氏病和老年痴呆症）中饮食疗法和身心疗法的应用。Dr Anderson在基础科学以及临床研究方面拥有丰富经验。攻读博士之前，曾在维克森林大学医学院的两个癌症研究实验室任实验室管理人。另外，还拥有体外培养技术的专业经验，包括：细胞研究、分子生物学（免疫印迹、RT – PCR、免疫细胞化学）、显微镜分析（明视野、荧光）、微生物学、分析化学、小鼠和大鼠体内模型（包括定向手术和微透析）等。Dr Anderson 已在同行评审期刊上发表了几十篇文章以及专书论文，曾多次出席国家级和国际级学术会议。2011年加盟理文编辑，担任编辑。

Dr Anderson’s PhD research focused on the effects of manganese toxicity and iron deficiency on the biology of the neurotransmitters GABA and norepinephrine. He is currently a postdoctoral research fellow at the Center for the Study of Complementary and Alternative Therapies at the University of Virginia. His research interests include the use of dietary and mind-body therapies for the prevention and management of neurodegenerative diseases such as Alzheimer’s disease and dementia. Dr Anderson has experience in basic science in addition to his current clinical research. Before his PhD, he was the laboratory manager of two cancer research labs at the Wake Forest University School of Medicine. Dr Anderson has expertise in various in vitro techniques, including cellular studies, molecular biology (western blotting, RT-PCR and immunocytochemistry), microscopy (brightfield and fluorescence), microbiology, and analytical chemistry, as well as in vivo work with mouse and rat models including stereotaxic surgery and microdialysis. Dr Anderson has over a dozen publications in peer-reviewed journals, as well as book chapters, and has presented at national and international conferences. He joined the Edanz Group as an editor in 2011.

Featured Editor

Expert in models and diagnosis of Parkinson's disease

Tinsley拥有南澳弗林得斯大学医学院博士学位。研究课题为“非病毒神经胶质细胞传染：中枢神经系统再生治疗战略”。博士后工作期间，在首位证明成年人大脑中神经形成的专家Peter Eriksson教授的神经干细胞实验室工作。之后重返澳大利亚，在霍华德•弗利研究所工作，研究帕金森氏疾病的模型和诊断。拥有十多年医学研究经验，曾在知名专业期刊发表作品，包括Annals of Neurology。2011年起为理文编辑工作，担任编辑。

Dr Tinsley completed his PhD at the School of Medicine at Flinders University of South Australia. His thesis title was "Non-Viral Glial Cell Transfection: A Therapeutic Strategy for CNS Regeneration." His post-doctoral training was in the neural stem cell laboratory of Prof Peter Eriksson, the first to demonstrate neurogenesis in the adult human brain. Dr Tinsley returned to Australia to work at the Howard Florey Institute, investigating models and diagnosis of Parkinson's disease. He has over ten years experience in medical research, and has published widely in leading journals in his field, including Annals of Neurology. Dr Tinsley began working as an editor with the Edanz Group in 2011.

Dr McAlpine的博士研究课题是炎症（特别是肿瘤坏死因子）对神经退行性疾病进展的影响，该项研究主要集中在阿尔茨海默氏症，部分工作涉及帕金森氏症。Dr McAlpine针对这些疾病大量使用了啮齿动物模型，并对染疫动物大脑的施药和基因治疗载体进行了研究。已发表了这一领域的研究文章以及评审文章。博士毕业后，在英国完成了一项有关自噬的奖学金博士后研究。2011年加入理文编辑。

Dr McAlpine's PhD research focused on the effects of inflammation, specifically Tumor Necrosis Factor, on the progression of neurodegenerative diseases. This research focused mainly on Alzheimer's disease, with some work on Parkinson's disease. She made extensive use of rodent models of these diseases, and administered both drugs and gene therapy vectors to the brains of affected animals. She has published both primary research articles and reviews on this topic. After her PhD, Dr McAlpine completed a postdoctoral fellowship studying autophagy in the UK. Dr McAlpine joined the Edanz Group as an editor in 2011.

Bass女士是一名医学学术和临床研究撰稿人、编辑。自2007年起一直从事研究基金申请书撰写、书稿编辑工作，并担任加州大学圣迭戈分校实验室的项目经理，协助多个领域的研究者进行研究，其中包括：医院政策和质量改进、放射学、医用物理学、纳米技术、材料科学和基因组学等不同领域。Bass女士还编辑了一些有关病人教育和补充/替代医疗的指导手册，并担任圣地亚哥一家健康保险公司的新闻稿件编辑工作。除了学术学位以外，Bass女士还于2004年获得圣迭戈州立大学科技写作高级证书。2011年加盟理文编辑，担任编辑。

Ms Bass is a science writer and editor focused on academic medicine and clinical research. Since 2007, she has served as a grant writer, manuscript editor, and project manager for many UC San Diego laboratories, assisting investigators involved in such diverse fields as hospital policy and quality improvement, radiology, medical physics, nanotechnology, materials science, and genomics. Ms Bass has also edited patient-education and complementary/alternative medicine guidebooks and newsletters for a San Diego-based health insurer. In addition to her academic degrees, in 2004 Ms Bass earned an Advanced Certificate in Technical & Scientific Writing from San Diego State University. Ms Bass joined the Edanz Group as an editor in 2011.

Featured Editor

Stem cell specialist

Arico先生过去几年里一直在澳大利亚科技界工作学习，在一些国际公认组织内从事研究工作（如昆士兰与加尔文医学研究所）。这一期间，他的研究主要集中在肿瘤免疫治疗和免疫学方面。Arico 先生还有在私营生物技术公司（分子诊断领域）的工作经历。2006年在莫纳什大学知名教授的指导下，完成了人类胚胎干细胞不可逆胚层分化的研究，获得了荣誉学位。擅长领域：细胞培养（包括人类和小鼠胚胎干细胞），利用胚胎干细胞和成年干细胞进行体外细胞分化，各种成像技术，细胞化验，流式细胞仪，细胞提纯技术，PCR，克隆，转染等。对组织工程技术、干细胞临床应用有着浓厚的兴趣。2011年开始为理文编辑工作，担任编辑。

Mr Arico has been working and studying in the Australian scientific sector for the past several years and has held research positions at internationally recognized organizations such as the Queensland and Garvan Institutes of Medical Research. During this time his research focused on Cancer Immunotherapy and Immunology. Mr Arico has also worked in the private biotechnology sector in the area of Molecular Diagnostics. Mr Arico completed his honors degree in 2006 under the direction of a prominent Professor of Stem Cell Sciences at Monash University researching definitive endoderm differentiation from human embryonic stem cells. His technical skills include: cell culture including human and mouse embryonic stem cells, in vitro cell differentiations using embryonic and adult stem cells, various imaging techniques, cell-based assays, flow cytometry, cell purification techniques, PCR, cloning and retroviral transfections. Mr Arico has a strong interest in tissue engineering technologies and the clinical use of stem cells. He began working as an editor with the Edanz Group in 2011.

Van Dervort女士的医学编辑生涯始于在W.B. Saunders Company（Elsevier旗下）担任制作编辑期间，每年负责编辑和排版的期刊稿件高达3000多页。她培养了一批新编辑，同时还负责稿件作者和主编之间的联络协调等。她的医学出版经验涵盖了生物医学和生命科学领域。2011年加盟理文编辑，担任编辑和医学撰搞人。

Ms. Van Dervort's career in medical editing began at W.B. Saunders Company (Elsevier), where she worked as a production editor, overseeing the copyediting and production of more than 3,000 journal pages each year.  She also trained new editors and served as liaison between manuscript authors and editors-in-chief. Her experience in medical publishing covers the biomedical and life sciences fields. She joined the Edanz Group as an editor and medical writer in 2011.

Featured Editor

Specialist biomedical writer

协助撰稿人撰写国际医学刊物投稿已有22年历史。最初于1988年为W.B. Saunders Company (Elsevier) 工作，一开始担任制作编辑，很快晋升为期刊部业务经理。1993年起转做自由职业编辑，在医学交流、出版和广告领域为客户提供帮助。为客户撰写和开发了一系列生物医学材料，包括科学海报、摘要、幻灯集、专论、档案、竞争力分析、专题文章、处方集、出版计划、CME/USMLE材料、作者简介、网站内容和产品培训材料等。工作内容涵盖大多数治疗领域，如肿瘤科、心脏科、内分泌科、神经科、外科、药理、数字成像和疼痛控制。Ms Seminara是美国医学作家协会会员，并任International Scleroderma Network高级编辑。此外，还是Senior Sez Games的创办者，向患有不同程度阿尔茨海默氏病的人提供帮助。2010年加盟理文编辑，担任编辑和撰稿人。

Ms Seminara has helped authors prepare manuscripts for international medical journals for over 22 years. Her career began at W.B. Saunders Company (Elsevier) in 1988, where she started as a Production Editor, soon becoming the Operations Manager of the Journals Department. Since 1993, she has been a freelance editor helping clients in the fields of medical communications, publishing, and advertising. Ms Seminara also writes and develops for clients an array of biomedical materials, including scientific posters, abstracts, slide kits, monographs, dossiers, competitive analyses, feature articles, formulary kits, publication plans, CME/USMLE materials, author biographies, web content, and product training materials. She works across a multitude of therapeutic areas, including oncology, cardiology, endocrinology, neurology, surgery, pharmacology, digital imaging, and pain management. Ms Seminara is a Member of the American Medical Writers Association and serves as Senior Editor for the International Scleroderma Network. She is the creator of Senior Sez Games for senior citizens, which are appropriate for people in various stages of Alzheimer's disease. Ms Seminara joined the Edanz Group as an editor and writer in 2010.

美国堪萨斯州曼哈顿岛堪萨斯州立大学知名名誉退休教授。在眼睛细胞生物和蛋白质化学领域拥有丰富经验，从事相关研究长达30余年。其研究长期以来得到了美国国立卫生研究院的资金支持。一直为多个国家和国际委员会从事视觉研究，其中包括国家眼科研究所科学顾问委员会、Lens & Cataract Panel of the National Eye Institute、视觉与眼科学研究理事委员会等。Takemoto教授出生于美国，祖籍日本，曾作为日本学术振兴会研究员广泛开展研究和考察活动。在同行评审期刊上发表了150余篇作品，于2011年加入理文，担任编辑。

Prof Takemoto is a University Distinguished Professor Emeritus at Kansas State University, Manhattan, KS, USA. He has extensive experience in the cell biology and protein chemistry of the eye, which he has studied for over 30 years. His research has been continuously funded by the National Institutes of Health of the US. He has served on numerous national and international boards dealing with vision research, including the Board of Scientific Counselors of the National Eye Institute, Lens & Cataract Panel of the National Eye Institute, and the Board of Directors of the Association for Research in Vision & Ophthalmology (ARVO). Prof Takemoto, though US-born, traces his ancestry back to Japan and has conducted research and traveled extensively in Japan as a Fellow of the Japan Society for the Promotion of Science. He has published over 150 peer-reviewed manuscripts, and joined the Edanz Group as an editor in 2011.

Milazzo先生自康奈尔大学毕业后，在一家临床前合同研究组织工作了10年，在那里负责一系列面向生物技术、制药和医疗器械企业的跨学科项目。后来在一家从事开发眼科、骨科、心血管用控释药物植入的生物技术公司任临床前研究主任，参与了多项向美国FDA提交的IND和NDA应用项目。后去新西兰攻读博士学位，曾与多家从事开发肽治疗肌肉萎缩疾病和癌症检测与监测分子诊断产品的生物技术企业合作。2010年提交了博士论文，题为“羊脂的发现 —  对皮下脂肪间充质干细胞和髌下脂肪间充质干细胞进行羊模型软骨缺损修复软骨能力方面的比较”。Milazzo先生的实验室经验涵盖了各种大型和小型研究动物模型的技术和手术技巧（尤其是骨科），其中包括：干细胞和软骨细胞的分离和培养、免疫组织化学、生化分析、组织病理标本制备与评估、显微镜技术、RNA提取和cDNA制备、基因芯片等。2011年加盟理文编辑，担任编辑。

After graduation from Cornell University, Mr Milazzo worked for 10 years at a preclinical contract research organization where he was in charge of multi-disciplinary programs for biotechnology, pharmaceutical and medical device companies. Later Mr Milazzo became the director of preclinical research for a biotechnology company developing controlled-release drug implants for ophthalmic, orthopedic, and cardiovascular use, contributing to several IND and NDA applications to the US FDA. Mr Milazzo moved to New Zealand for his PhD studies, and has been working with biotechnology companies developing peptide therapies for muscle wasting disease and molecular diagnostic products for cancer detection and monitoring. His PhD thesis submitted in 2010, was entitled "Sheep Fat Bingo - A Comparison of Subcutaneous Adipose-Derived Mesenchymal Stem Cells with Infrapatellar Adipose-Derived Mesenchymal Stem Cells with Regard to their Chondrogenic Ability in a Sheep Model of Osteochondral Defect Repair". Mr Milazzo’s laboratory expertise includes techniques and surgical skills (particularly orthopedic) associated with a variety of large and small research animal models. These include stem cell and chondrocyte isolation and culture, immunohistochemistry, biochemical assay, histopathology specimen preparation and evaluation, microscopy, RNA extraction and cDNA preparation, and gene microarray. Mr Milazzo joined the Edanz Group as an editor in 2011.

Featured Editor

Recently published in Diabetes Care, Archives of Internal Medicine, Journal of Clinical Endocrinology and Metabolism, Journal of Sexual Medicine, Diabetologia, and the American Journal of Clinical Nutrition

Dr Janiszewski 是一位高产的作者，发表有16篇同行评审报告、文摘以及专书论文，领域涉及肥胖、身体组成、运动缺乏、心血管疾病、2型糖尿病、性功能障碍、饮食、锻炼和肥胖控制等领域。这些文章均发表在具有较高影响因子的刊物上，包括Diabetes Care、Archives of Internal Medicine、Journal of Clinical Endocrinology and Metabolism、Journal of Sexual Medicine、Diabetologia、American Journal of Clinical Nutrition等。Dr Janiszewski先在是一位医学撰稿人，在PLoS Blogs Network上有自己的医学博客和播客。他在社交媒体领域具有丰富的经验，现任ResearchBlogging.org健康/临床研究编辑。Dr Janiszewski从2009年起加入理文编辑，担任医学撰稿人。

Dr Janiszewski is a well published author with 16 peer-reviewed reports, plus abstracts and a book chapter on topics including obesity, body composition, physical inactivity, cardiovascular disease, type-2 diabetes, sexual dysfunction, diet, exercise, and obesity management. His research has been published in high impact journals including Diabetes Care, Archives of Internal Medicine, the Journal of Clinical Endocrinology and Metabolism, the Journal of Sexual Medicine, Diabetologia, and the American Journal of Clinical Nutrition. Dr Janiszewski now works as a medical writer and has a medical blog and podcast on PLoS Blogs Network. He is an expert in social media and currently holds the position of Health/Clinical Research Editor at ResearchBlogging.org. Dr Janiszewski began working with the Edanz Group as a medical writer in 2009.

Dr Rice曾在纽约西奈山医学院血液/肿瘤科以及西北大学Robert H. Lurie 综合性肿瘤中心工作。博士后期间主要研究转路抑制机制，致力于t(11;17) APL中发现的PLZF和PLZF-RARa是如何通过此机制对融合癌蛋白基因表达进行调控，且在其失调后如何最终导致白血病的形成。Dr Rice曾进行过全基因筛选和相关通路及候选染色体的判定，以便针对有选择性的治疗靶向做出可检验的假设。此外，还曾与Dana-Farber癌症研究所（波士顿）和麦吉尔大学（蒙特利尔）的独立研究人员多次进行项目合作，试验癌蛋白转化细胞对特定药物配方的敏感度。曾在Blood、Genes and Development以及Blood Cancer Journal等多家国际知名期刊上发表文章，并为PNAS、Blood、Oncogene和Leukemia担任审稿人。与他人合作撰写了两篇专书论文，并在美国血液病学会的多个会议场合发表。自2011年起开始为理文编辑工作。

Dr Rice worked within the Division of Hematology/Oncology at the Mount Sinai School of Medicine in New York and at the Robert H. Lurie Comprehensive Cancer Centre of Northwestern University. Dr Rice’s Post-Doctoral studies focused on transcriptional mechanisms by which PLZF and the PLZF-RARa fusion oncoprotein found in t(11;17) APL regulate gene expression, and ultimately how their dysregulation contributes to leukemogenesis. Dr Rice has experience in performing whole genome screens and identifying relevant pathways and candidate genes to formulate testable hypothesis with the aim of selective, therapeutic targeting. She was also involved in several collaborative projects with independent researchers at the Dana-Farber Cancer Institute (Boston) and McGill University (Montreal) testing the sensitivity of oncoprotein-transformed cells to specific drug compounds. Dr Rice has published in internationally recognized journals including Blood, Genes and Development and Blood Cancer Journal and has reviewed for PNAS, Blood, Oncogene and Leukemia. She has also written two book chapters and presented her work on several occasions at American Society of Hematology meetings. Dr Rice began editing for the Edanz Group in 2011.

从牛津大学动物学获得学士学位和博士学位后，Dr Prosser进入位于英国阿宾登医学出版公司（现隶属于Elsevier Health Sciences），担任医疗教育出版物的专职编辑。1998年起出任Medicine杂志总编，直至2006年。之后开始自由职业生涯，担任医学撰稿人和手稿编辑人。Dr Prosser是一位在生物医学和健康科学领域颇有成就和经验丰富的编辑和作家，于2006年开始供职理文集团。

After obtaining a BA and PhD in zoology from the University of Oxford, Dr Prosser joined the Medicine Publishing Company, Abingdon, UK, (now part of Elsevier Health Sciences) as a Staff Editor of medical educational publications. In 1998, she became Managing Editor of the journal Medicine, a position she held until 2006, when she began as a freelance science and medical writer and manuscript editor. Dr Prosser, an accomplished and highly experienced biomedical and health sciences editor and writer, began working with Edanz Group in 2006.